ABSTRACT
OBJECTIVE: The objective of this study was to compare diagnostic yield and complication rate in needle biopsy (NB) of renal hilar and cortical masses. MATERIALS AND METHODS: With institutional review board approval, we retrospectively studied 195 patients (120 men, 75 women; mean age ± SD, 67 ± 13 years old) who underwent ultrasound-guided renal mass NB between January 2013 and December 2017. Operator years of experience, biopsy technique (coaxial or successive), needle gauge (22-gauge fine-needle aspiration, 18-gauge core-needle, or both), number of passes, postprocedural complication, and histopathologic diagnoses were recorded. A radiologist who was blinded to histopathologic diagnoses recorded mass location (upper pole, interpolar region, lower pole) and percentage of hilar involvement. Comparisons were performed using independent t and chi-square tests. RESULTS: Of the masses biopsied, 5.6% (11/195) were 100% hilar (mean hilar involvement, 20.8% ± 29.8%; range, 0-100%). Mean lesion size was 44 ± 27 mm (range, 12-157 mm). NB diagnosis was established in 84.6% (165/195) of masses, and 15.4% (30/195) of biopsies were inconclusive, with no association with size (p = 0.55) or percentage of hilar involvement (p = 0.756). In the purely hilar masses, diagnosis was established in 72.7% (8/11) compared with 85.3% (157/184) with any cortical involvement (p = 0.265). There was no association between diagnosis and operator years of experience, biopsy technique, needle gauge, or number of passes (p > 0.05). Bleeding occurred after biopsy in 7.7% (15/195) of cases, was associated with percentage of hilar involvement (39.3% ± 44.9% vs 19.3% ± 27.8%; p = 0.012), and was more common in purely hilar masses (36.4% [4/11] vs 5.6% [11/195]; p < 0.001). Complications were not associated with any other feature (p > 0.05). CONCLUSION: Percutaneous biopsy of renal hilar masses is technically feasible with diagnostic yield similar to that of cortical masses but with postprocedural bleeding more often than what is seen with cortical masses.
Subject(s)
Biopsy, Fine-Needle/methods , Image-Guided Biopsy/methods , Kidney Neoplasms/pathology , Ultrasonography, Interventional/methods , Aged , Biopsy, Fine-Needle/adverse effects , Contrast Media , Female , Hemorrhage/etiology , Humans , Image-Guided Biopsy/adverse effects , Kidney Neoplasms/diagnostic imaging , Magnetic Resonance Imaging , Male , Middle Aged , Retrospective Studies , Tomography, X-Ray ComputedABSTRACT
The Liver Imaging Reporting and Data System (LI-RADS®) is an imaging-based diagnostic system applicable in patients at high risk of hepatocellular carcinoma (HCC). In LI-RADS, each liver observation is assigned a category that reflects probability of benignity, HCC, or other malignancy. Familiarity with the LI-RADS diagnostic algorithm is necessary to appropriately implement LI-RADS in clinical practice. This review discusses steps necessary for application of the LI-RADS algorithm and provides examples illustrating each step.
Subject(s)
Algorithms , Carcinoma, Hepatocellular/diagnostic imaging , Liver Neoplasms/diagnostic imaging , Magnetic Resonance Imaging/methods , Tomography, X-Ray Computed/methods , Carcinoma, Hepatocellular/pathology , Contrast Media , Humans , Liver Neoplasms/pathologyABSTRACT
Hepatocarcinogenesis is a multi-step process characterized by progressive cellular and molecular dedifferentiation of hepatocytes and culminating in the emergence of hepatocellular carcinoma (HCC). Knowledge of hepatocarcinogenesis is important because familiarity with the associated imaging features can lead to improved diagnosis of HCC at its early stages. The article reviews the alterations that accumulate leading to HCC result in abnormal imaging features, many of which are included in LI-RADS v2017 as major and ancillary features.
Subject(s)
Algorithms , Carcinogenesis/classification , Carcinoma, Hepatocellular/diagnostic imaging , Contrast Media/administration & dosage , Liver Neoplasms/diagnostic imaging , Magnetic Resonance Imaging/methods , Tomography, X-Ray Computed/methods , Carcinoma, Hepatocellular/pathology , Diagnosis, Differential , Humans , Liver Neoplasms/pathology , Neoplasm StagingABSTRACT
The Liver Imaging Reporting and Data System (LI-RADS) uses an algorithm to assign categories that reflect the probability of hepatocellular carcinoma (HCC), non-HCC malignancy, or benignity. Unlike other imaging algorithms, LI-RADS utilizes ancillary features (AFs) to refine the final category. AFs in LI-RADS v2017 are divided into those favoring malignancy in general, those favoring HCC specifically, and those favoring benignity. Additionally, LI-RADS v2017 provides new rules regarding application of AFs. The purpose of this review is to discuss ancillary features included in LI-RADS v2017, the rationale for their use, potential pitfalls encountered in their interpretation, and tips on their application.
Subject(s)
Algorithms , Carcinoma, Hepatocellular/diagnostic imaging , Liver Neoplasms/diagnostic imaging , Carcinoma, Hepatocellular/pathology , Contrast Media , Humans , Liver Neoplasms/pathology , Magnetic Resonance Imaging/methods , Tomography, X-Ray Computed/methods , Ultrasonography/methodsABSTRACT
OBJECTIVE: The purpose of this study was to evaluate the ability of ultrasound (US) to characterize hyperattenuating cysts detected as indeterminate hyperattenuating renal lesions on unenhanced and single phase enhanced CT. MATERIALS AND METHODS: A total of 107 consecutive homogeneously hyperattenuating renal lesions underwent gray-scale and Doppler US at our institution between 2010 and 2013. Two radiologists who were unaware of the final diagnosis retrospectively evaluated US images for visibility and diagnosis (simple cyst, intermediate complexity cyst, cystic or solid mass showing internal flow on Doppler US, or indeterminate). A third radiologist assessed lesion size, location, and distance to skin on CT and US. US visibility was compared using chi-square and independent t tests. Consensus US interpretation was compared with reference standard diagnoses, and accuracy for diagnosis of hyperattenuating cysts was tabulated. RESULTS: Mean lesion size ± SD was 20 ± 16 mm (range, 6-96 mm) and mean distance to skin on CT was 62 ± 25 mm (range, 18-125 mm). In all, 89.7% (96/107) of the lesions were visible on US, including all lesions that were 15 mm or larger. Nonvisible lesions were smaller than visible ones (10.0 ± 3.6 mm vs 20.7 ± 16.3 mm, p = 0.03) regardless of location (p > 0.05). CT overestimated lesion distance to skin compared with US (46.6 ± 18.6 mm, p < 0.001). Final diagnoses for US visible lesions (n = 96) were hyperattenuating cyst (n = 66), Bosniak IIF cyst (n = 13), and cystic or solid neoplasm (n = 15); two patients were lost to follow-up. Of the 66 hyperattenuating cysts, 54 (81.8%) appeared as simple cysts on US with sensitivity and specificity for diagnosis of hyperattenuating cyst of 81.8% (95% CI, 75.6-84.3%) and 92.9% (95% CI, 78.1-98.7%), respectively. The other 12 (18.2%) hyperattenuating cysts appeared complex. Two of the 13 Bosniak IIF lesions were incorrectly classified as simple cysts with US. Including the 11 (10%) nonvisible lesions reduced sensitivity and specificity for diagnosis of hyperattenuating cyst to 73.0% (95% CI, 66.9-75.9%) and 89.7% (95% CI, 74.2-97.2%), respectively. CONCLUSION: US can further characterize hyperattenuating cysts presenting as indeterminate hyperattenuating renal lesions on CT in the majority of cases.
Subject(s)
Kidney Diseases/diagnostic imaging , Tomography, X-Ray Computed/methods , Ultrasonography/methods , Aged , Contrast Media , Diagnosis, Differential , Female , Humans , Kidney Diseases/pathology , Male , Middle Aged , Retrospective Studies , Sensitivity and SpecificityABSTRACT
A 63-yr-old woman, known case of ulcerative colitis, was diagnosed with sclerosing cholangitis 2 years back. She was admitted for investigation of abdominal discomfort, fatigue with elevated alkaline phosphatase and deranged liver function test. Imaging studies (computerised tomography and magnetic resonance imaging) demonstrated a normal biliary tree with focal hepatic lesion which was showing features of cholangiocarcinoma. Ultrasound guided biopsy of the lesion surprisingly revealed non caseating granulomata. Granulomatous hepatitis occurs in less than 1 percent of cases of inflammatory bowel disease. A clinical diagnosis of isolated granulomatous hepatitis was established as the lesion remained stable on follow up and no other cause for it was identified on further investigation. Although the differential diagnosis of focal hepatic lesion in patients with ulcerative colitis with sclerosing cholangitis is wide, granulomatous hepatitis presenting as focal mass lesion mimicking cholangiocarcinoma has never been described previously.
Subject(s)
Bile Duct Neoplasms/diagnosis , Bile Ducts, Intrahepatic , Cholangiocarcinoma/diagnosis , Colitis, Ulcerative/complications , Granuloma/diagnosis , Hepatitis A/diagnosis , Bile Duct Neoplasms/etiology , Biopsy , Cholangiocarcinoma/etiology , Cholangitis, Sclerosing/diagnosis , Cholangitis, Sclerosing/etiology , Colitis, Ulcerative/diagnosis , Diagnosis, Differential , Female , Granuloma/etiology , Hepatitis A/etiology , Humans , Magnetic Resonance Imaging , Middle Aged , Predictive Value of Tests , Tomography, X-Ray ComputedSubject(s)
Appendicitis/diagnostic imaging , Acute Disease , Contrast Media , Diagnosis, Differential , Female , Gastrointestinal Diseases/diagnostic imaging , Genital Diseases, Female/diagnostic imaging , Genital Diseases, Female/pathology , Humans , Image Enhancement/methods , Magnetic Resonance Imaging/methods , Male , Tomography, X-Ray Computed/methods , Ultrasonography, Doppler/methods , Urologic Diseases/diagnostic imagingABSTRACT
INTRODUCTION: Preoperative prostate cancer stage predicts prognosis and affects treatment decisions. The purpose of this study was to estimate the sensitivity and specificity of surface coil magnetic resonance imaging (MRI) for prostate cancer stage using surgical pathologic data as the reference standard. METHODS: High-risk patients (>/=cT3 or PSA >/=20 ng/mL or Gleason >/=8) and selected intermediate-risk patients (clinically bulky disease on exam or biopsy, cT2b/c, or Gleason 7 with >/=3 of 5 biopsy cores positive in a lobe) routinely received a pelvic MRI at our institution. The images of identified patients were reviewed by one radiologist who was blinded to clinical information. The radiologist reported presence or absence of tumour within each lobe of the prostate. Extraprostatic extension (EPE), seminal vesicle (SV) invasion and pelvic lymph node (PLN) metastasis were also reported. Radiological findings were compared with prostatectomy pathology reports. RESULTS: During the study period, about 320 radical prostatectomies were performed. Of these, 32 had a preoperative surface coil pelvic MRI adequate for analysis. Pathologically, 53 of 64 (82.8%) prostate lobes contained tumour, 17 (26.6%) lobes had associated EPE, 12 (18.8%) had SV involvement and 7 (10.9%) sets of PLNs contained cancer. Magnetic resonance imaging sensitivity and specificity were, respectively, 94.3% and 81.8% for tumour location, 82.4% and 87.2% for EPE, 83.3% and 92.3% for SV invasion and 71.4% and 94.7% for PLN involvement. INTERPRETATION: Surface coil MRI accurately stages many prostate cancer patients with elevated risk of extraprostatic disease. This mode of imaging may be reasonable at centres that do not have endorectal coil MRI.
ABSTRACT
OBJECTIVE: Endometriosis is defined as tissue resembling the endometrium occurring outside the uterus. The purpose of this article is to familiarize the radiologist with the wide spectrum of pelvic endometriosis and to review the distinctive imaging findings. Infrequent manifestations of endometriosis, including malignant degeneration, scar endometriosis, association with ascites, and invasive endometriosis, are described. CONCLUSION: The manifestations of endometriosis commonly present a challenge to the gynecologist and radiologist. Familiarity with its varied presentations may allow accurate diagnosis.